Line 23: |
Line 23: |
| ==WHO Classification Pages (Includes Links to Content)== | | ==WHO Classification Pages (Includes Links to Content)== |
| | | |
− | *[[Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] | + | *[[HAEM5:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion]] |
− | *[[Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] | + | *[[HAEM5:Acute myeloid leukaemia with CBFB::MYH11 fusion]] |
− | *[[Acute Promyelocytic Leukemia (APL) with PML-RARA]] | + | *[[HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion]] |
− | *[[Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] | + | *[[HAEM5:Acute myeloid leukaemia with KMT2A rearrangement]] |
− | *[[Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214]] | + | *[[HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion]] |
− | *[[Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] | + | *[[HAEM5:Acute myeloid leukaemia with MECOM rearrangement]] |
− | *[[Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] | + | *[[HAEM5:Acute myeloid leukaemia with RBM15::MRTFA fusion]] |
− | *[[Acute Myeloid Leukemia (AML) with BCR-ABL1]] | + | *[[HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion]] |
− | *[[Acute Myeloid Leukemia (AML) with Mutated NPM1]] | + | *[[HAEM5:Acute myeloid leukaemia with NPM1 mutation]] |
− | *[[Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA]] | + | *[[HAEM5:Acute myeloid leukaemia with CEBPA mutation]] |
− | *[[Acute Myeloid Leukemia (AML) with Mutated RUNX1]] | + | *[[HAEM4:Acute Myeloid Leukemia (AML) with Mutated RUNX1]] |
| | | |
| ==Other Related Pages (Includes Links to Content)== | | ==Other Related Pages (Includes Links to Content)== |
| | | |
− | *[[Acute Myeloid Leukemia (AML) with Mutated FLT3]] | + | *[[HAEM5:Myeloid/lymphoid neoplasm with FLT3 rearrangement]] |
| | | |
| ==Additional Information== | | ==Additional Information== |